-
Levacetylleucine, sold
under the
brand name Aqneursa, is a
medication used for the
treatment of
neurological manifestations of Niemann-Pick
disease type...
- infections, and vomiting.
Levacetylleucine was
approved for
medical use in the
United States in
September 2024.
Levacetylleucine is the
second medication...
- others, and used in the
treatment of vertigo) and N-acetyl-L-leucine (
levacetylleucine, sold
under the
brand name Aqneursa, and used for the
treatment of...
- Disease, Type C.
Levacetylleucine (Aqneursa) was
approved for
medical use in the
United States in
September 2024.
Levacetylleucine is the
second medication...
- commercial-stage
biopharmaceutical company based in Austin,
Texas which developed levacetylleucine,
commercially known as AQNEURSA, for the
treatment of neurological...
-
leustatin leustatin (R.W.
Johnson Pharmaceutical Research Institute)
levacetylleucine (INN)
levacetylmethadol (INN)
levalbuterol propionate (USAN) levallorphan...
- 173.21 g/mol,
exact m****: 173.1052 u) may
refer to:
Acetylleucine Levacetylleucine Swainsonine SCH-50911 This set
index page
lists chemical structure...
-
research and development. 2018-04-20.
Retrieved 2024-12-11. "AQNEURSA™ (
levacetylleucine)
NowApproved & Available". aqneursa.
Retrieved 2024-12-11. Williams...
